Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China
· Delayed Price · Currency is CNY 25.63
+0.05 (0.20%)
Feb 21, 2025, 3:00 PM CST
SHA:600196 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 62,237 | 61,592 | 86,922 | 113,862 | 125,791 | 65,086 | Upgrade
|
| Market Cap Growth | -5.62% | -29.14% | -23.66% | -9.48% | 93.27% | 12.32% | Upgrade
|
| Enterprise Value | 93,272 | 89,228 | 110,109 | 134,998 | 147,717 | 86,903 | Upgrade
|
| Last Close Price | 25.63 | 24.74 | 34.35 | 47.08 | 51.64 | 25.26 | Upgrade
|
| PE Ratio | 32.76 | 25.81 | 23.30 | 24.08 | 34.34 | 19.59 | Upgrade
|
| Forward PE | 22.38 | 21.48 | 19.36 | 20.43 | 30.68 | 17.62 | Upgrade
|
| PS Ratio | 1.66 | 1.49 | 1.98 | 2.92 | 4.15 | 2.28 | Upgrade
|
| PB Ratio | 1.44 | 1.09 | 1.61 | 2.35 | 2.74 | 1.66 | Upgrade
|
| P/TBV Ratio | 2.82 | 2.88 | 3.99 | 5.83 | 6.40 | 4.35 | Upgrade
|
| P/OCF Ratio | 16.80 | 18.04 | 20.61 | 28.91 | 48.76 | 20.20 | Upgrade
|
| PEG Ratio | 1.02 | 1.02 | 1.02 | 1.02 | 2.05 | 0.89 | Upgrade
|
| EV/Sales Ratio | 2.24 | 2.16 | 2.51 | 3.46 | 4.87 | 3.04 | Upgrade
|
| EV/EBITDA Ratio | 16.31 | 23.25 | 19.87 | 32.27 | 36.18 | 23.64 | Upgrade
|
| EV/EBIT Ratio | 38.89 | 75.34 | 32.19 | 53.22 | 56.42 | 36.52 | Upgrade
|
| EV/FCF Ratio | -450.72 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.59 | 0.62 | 0.56 | 0.53 | 0.52 | 0.56 | Upgrade
|
| Debt / EBITDA Ratio | 6.08 | 8.54 | 5.25 | 5.86 | 5.63 | 5.74 | Upgrade
|
| Asset Turnover | 0.37 | 0.38 | 0.44 | 0.44 | 0.38 | 0.39 | Upgrade
|
| Inventory Turnover | 2.84 | 3.01 | 3.76 | 3.82 | 3.03 | 3.20 | Upgrade
|
| Quick Ratio | 0.68 | 0.73 | 0.78 | 0.75 | 0.71 | 0.89 | Upgrade
|
| Current Ratio | 0.92 | 1.00 | 1.06 | 1.04 | 1.01 | 1.17 | Upgrade
|
| Return on Equity (ROE) | 4.79% | 5.23% | 7.70% | 10.55% | 9.25% | 10.28% | Upgrade
|
| Return on Assets (ROA) | 1.33% | 0.67% | 2.13% | 1.79% | 2.05% | 2.03% | Upgrade
|
| Return on Capital (ROIC) | 1.64% | 0.84% | 2.70% | 2.21% | 2.50% | 2.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.08% | 1.49% | 4.63% | 3.96% | 4.45% | 4.05% | Upgrade
|
| Earnings Yield | 3.40% | 3.87% | 4.29% | 4.15% | 2.91% | 5.10% | Upgrade
|
| FCF Yield | -0.33% | -3.12% | -1.92% | -0.91% | -1.48% | -1.14% | Upgrade
|
| Dividend Yield | 1.05% | 1.09% | 1.22% | 1.19% | 0.83% | 1.54% | Upgrade
|
| Payout Ratio | 97.52% | 102.89% | 63.64% | 40.48% | 50.09% | 56.13% | Upgrade
|
| Buyback Yield / Dilution | -0.42% | -2.40% | -1.74% | - | - | -1.57% | Upgrade
|
| Total Shareholder Return | 0.64% | -1.31% | -0.51% | 1.19% | 0.83% | -0.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.